LibreOffice 25.8.1 brings almost 100 bug, crash and other regression fixes. This is the first of several planned point updates to the latest stable release series.

Regenxbio's RGX-121 gene therapy for Hunter syndrome is the main catalyst, with FDA approval targeted for February 2026.

Subscribers to Chart of the Week received this commentary on Sunday, August 17. Hello friends. An immense thank you to everyone that’s subscribed in the last week. We’re so excited to see where this ...

“A lot of people want me to lie and be like I hated it,” she said. “I’m not even gonna front. It saved me. It really saved me ...

Fans and members of the media are going to have to wait until Sunday afternoon, to find out who's going to start for the Gamecocks. Shane Beamer hasn't released a depth chart yet. As of Wednesday ...

NASCAR appealed that decision and the Fourth Circuit of Appeals overturned it. As far as NASCAR is concerned, it holds the four charters 23XI and Front Row gave up the rights to by not signing the new ...

Oklahoma released its official depth chart for Week 1 of the 2025 season as the Sooners enter Year 4 under head coach Brent Venables. NORMAN — The 2025 season is here for Brent Venables and the ...

Objectives This study uses nationally representative survey data from the USA to estimate the relationship between a history of heart attack or stroke with the prevalence of mental health symptoms.

ORLANDO, Florida, Aug 14 (Reuters) - The U.S. economy seems to be chugging along fairly smoothly, if a little too slowly for some observers' liking. Under the bonnet, however, the picture is more ...

Akebia's post-earnings dip offers a buying opportunity as Vafseo's adoption and market expansion drive revenue growth.

This study illustrates a valuable application of BID-seq to bacterial RNA, allowing transcriptome-wide mapping of pseudouridine modifications across various bacterial species. The evidence presented ...